Double Jeopardy: Schizophrenia and Substance Use

REFERENCES

• Regier D. A., Farmer M. E., Rae D. S., et al. Comorbidity of mental disorders with alcohol and other drug abuses. JAMA 1990; 264: 2511–2518
   PubMed Web of Science ®Google Scholar
• Westermeyer J. Schizophrenia and substance abuse. Review of Psychiatry, A. Tasman, M. R. Riba. American Psychiatric Press, Washington, D.C. 1992; 11: 379–401
   Google Scholar
• Drake R. E., Osher F. C., Noordsy D. M., et al. Diagnosis of alcohol use disorders in schizophrenia. Schizophr. Bull. 1990; 16: 57–67
   PubMed Web of Science ®Google Scholar
• El-Guebaly N., Hodgkins D. C. Schizophrenia and substance abuse: prevalence issues. Can. J. Psychiatry 1992; 37: 704–710
   PubMed Web of Science ®Google Scholar
• Selzer J. A., Lieberman J. A. Schizophrenia and substance abuse. Psychiatr. Clin. North Am. 1993; 16: 401–412
   PubMed Web of Science ®Google Scholar
• Cohen E., Henkin I. Prevalence of substance abuse by seriously mentally ill patients in a partial hospital program. Hospital Community Psychiatry 1993; 44: 178–180
   PubMedGoogle Scholar
• Inderbitzin L. B., Scheller-Gilkey G., Lewine R. R.J., et al. A double-blind dosage reduction trial of fluphenazine decanoate in chronic, unstable schizophrenic patients. Am. J. Psychiatry 1994; 151: 1753–1759
   PubMed Web of Science ®Google Scholar
• Swofford C. D., Kasckow J. W., Scheller-Gilkey G., et al. Substance use: a powerful predictor of relapse in schizophrenia. Schizophr. Res. 1996; 20: 145–151
   PubMed Web of Science ®Google Scholar
• Overall J. E., Gorham D. E. The brief psychiatric rating scale. Psychol. Rep. 1962; 10: 799–812
   Web of Science ®Google Scholar
• Vardy M. M., Kay S. R. LSD psychosis or LSD-induced schizophrenia? A multimethod inquiry. Arch. Gen. Psychiatry 1983; 40: 877–883
   PubMed Web of Science ®Google Scholar
• Strassman R. J. Adverse reactions to psychedelic drugs: a review of the literature. J. Nerv. Ment. Dis. 1984; 172: 577–595
   PubMed Web of Science ®Google Scholar
• Hanson G. R., Singh N., Merchant K., et al. Responses of limbic and extrapyramidal neurotensin systems to stimulants of abuse: involvement of dopaminergic mechanisms. Ann. N.Y. Acad. Sci. 1992; 668: 165–172
   PubMed Web of Science ®Google Scholar
• Silver H., Abboud E. Drug abuse in schizophrenia: comparison of patients who began drug abuse before their first admission with those who began abusing drugs after their first admission. Schizophr. Res. 1994; 13: 57–63
   PubMed Web of Science ®Google Scholar
• Bartels S. J., Teague G. B., Drake R. F., et al. Substance abuse in schizophrenia: service utilization and costs. J. Nerv. Ment. Dis. 1993; 181: 227–232
   PubMed Web of Science ®Google Scholar
• Turner W. M., Tsuang M. T. Impact of substance abuse on the course and outcome of schizophrenia. Schizophr. Bull. 1990; 16: 87–95
   PubMed Web of Science ®Google Scholar
• Crow T. J. Molecular pathology of schizophrenia: more than one disease process?. Br. Med. J. 1980; 280: 66
   PubMed Web of Science ®Google Scholar
• Lysaker P., Bell M., Beam-Goulet J., et al. Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. J. Nerv. Ment. Dis. 1994; 182: 109–112
   PubMed Web of Science ®Google Scholar
• Koob G. F., Robledo P., Markou A., et al. The mesolimbic circuit in drug dependence and reward: a role for the extended amygdala. Limbic Motor Circuits and Neuropsychiatry, P. W. Kalivas, C. D. Barnes. CRC Press, Boca Raton, Florida 1993
   Google Scholar
• Weiden P. J., Mann J. J., Frances A. Is neuroleptic dysphoria a healthy response?. Compr. Psychiatry 1989; 30: 546–552
   PubMed Web of Science ®Google Scholar
• Kaplan H. I., Sadock B. J. Pocket Handbook of Psychiatric Drug Treatment. Williams and Wilkins, Baltimore, Maryland 1993
   Google Scholar
• Cooper J. R., Bloom F. E., Roth R. H. The Biochemical Basis of Neuropharmacology, 6th ed. Oxford University Press, New York 1991
   Google Scholar
• Siris S. G., Kane J. M., Frechen K., et al. Histories of substance abuse in patients with post psychotic depressions. Compr. Psychiatry 1988; 29: 550–557
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., rev., Author, Washington, D.C. 1987
   Google Scholar
• Rothpearl A. B., Mohs R. C., Davis K. L. Statistical power in biological psychiatry. Psychiatry Res. 1981; 5: 257–266
   PubMed Web of Science ®Google Scholar
• SPSS, Incorporated. SPSS: The Statistical Package for the Social Sciences. Author, Chicago, Illinois
   Google Scholar
• Bezchlibnyk-Butler K. Z., Jeffries J. J., Bredin S. B., et al. Clinical Handbook of Psychotropic Drugs. 2nd rev. ed., Hogrefe and Huber Publishers, Lewiston, New York 1990
   Google Scholar
• Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Abnormal Involuntary Movement Scale (AIMS). NIMH Treatment Strategies in Schizophrenia Study. Author, Rockville, Maryland 1985
   Google Scholar
• Drake R. E., Wallach M. A. Substance abuse among the chronic mentally ill. Hospital Community Psychiatry 1989; 40: 1041–1046
   PubMedGoogle Scholar
• DeQuardo J. R., Carpenter C. F., Tandon R. Patterns of substance abuse in schizophrenia: nature and significance. J. Psychiatr. Res. 1994; 28: 267–275
   PubMed Web of Science ®Google Scholar
• Kivlahan D. R., Heiman J. R., Wright R. C., et al. Treatment cost and rehospitalization rate in schizophrenic outpatients with a history of substance abuse. Hospital Community Psychiatry 1991; 42: 609–614
   PubMedGoogle Scholar
• Green J. H. Frequent rehospitalization and noncompliance with treatment. Hospital Community Psychiatry 1988; 39: 963–966
   PubMedGoogle Scholar